"Classic" Guillain-Barré Syndrome
Immune/AntibodyOMIM 139393
W
View full entry on WUSTL Neuromuscular
antibody/gbs.htm#"Classic" Guillain-Barré Syndrome
Overview
From WUSTL NeuromuscularAutoantibodies Clinical features Electrodiagnostic Laboratory Morbidity Other features Pathology Prodrome Prognosis Therapy English translation: By Bassam Malo MD Epidemiology Incidence: 1 to 2/100,000/year Male: Female = 1.25: 1 Peak ages: Bimodal Children & Young adults > 55 years Zika infection: Colombia Winter month peak: United States, Australia & Asia Genetic risk factors 38 Familial cases Reported associations with occurrence, prognosis & severity of GBS Conflicting results FcγRIIa-H131 allele homozygosity (vs R131) 4 More common than in healthy controls Higher risk for severe disease t
OMIM Entries
Related Conditions
Shared genesAcute Immune Polyneuropathies
GD1APATHOLOGY
Acute Motor (Axonal) Neuropathy (AMAN)
IIGQ1BGM1
ACUTE NEUROPATHIES
GD1A
Antibodies vs Glycolipids & Glycoproteins
GM1MAGGQ1B
Chronic Immune Demyelinating Neuropathies: Variants
GD1AMOTORGM1
Classification of Acute Immune Neuropathies
GD1A
Demyelinating ataxic neuropathy with IgM binding to GalNAc-GD1a and GM2 gangliosides
GD1AACUTECHRONIC
Distal Motor Axonal Neuropathies: "Distal Lower Motor Neuron Syndromes"
GD1A
External Resources
Data sourced from the Washington University Neuromuscular Disease Center. For clinical use, always refer to primary sources.